0001415889-23-015195.txt : 20231116 0001415889-23-015195.hdr.sgml : 20231116 20231116161848 ACCESSION NUMBER: 0001415889-23-015195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231114 FILED AS OF DATE: 20231116 DATE AS OF CHANGE: 20231116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaBarre Michael J. CENTRAL INDEX KEY: 0001507174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32335 FILM NUMBER: 231414835 MAIL ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001159036 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 880488686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 794-8889 MAIL ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC DATE OF NAME CHANGE: 20040312 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC DATE OF NAME CHANGE: 20010912 4 1 form4-11162023_091135.xml X0508 4 2023-11-14 0001159036 HALOZYME THERAPEUTICS, INC. HALO 0001507174 LaBarre Michael J. C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL SAN DIEGO CA 92130 false true false false SVP, CHIEF TECHNICAL OFFICER 1 Common Stock 2023-11-14 4 M 0 8292 13.81 A 160203 D Common Stock 2023-11-14 4 S 0 8292 39.079 D 151911 D Common Stock 2023-11-14 4 M 0 1708 16.78 A 153619 D Common Stock 2023-11-14 4 S 0 1708 39.079 D 151911 D Common Stock 2023-11-15 4 M 0 10000 13.81 A 161911 D Common Stock 2023-11-15 4 S 0 10000 39.788 D 151911 D Option to Purchase Common Stock 13.81 2023-11-14 4 M 0 8292 0 D 2025-02-04 Common Stock 8292 18533 D Option to Purchase Common Stock 16.78 2023-11-14 4 M 0 1708 0 D 2028-07-02 Common Stock 1708 292 D Option to Purchase Common Stock 13.81 2023-11-15 4 M 0 10000 0 D 2025-02-04 Common Stock 10000 8533 D The option exercises and sales reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. Represents a weighted average sales price per share. These shares were sold at prices ranging from $38.75 to $39.62. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents a weighted average sales price per share. These shares were sold at prices ranging from $39.335 to $40.155. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. This option was granted on February 4, 2015 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. This option was granted on July 2, 2018 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. /s/ James R. Oehler, Attorney-in-Fact 2023-11-16